Literature DB >> 15766942

Improving protective efficacy of BCG vaccination for wildlife against bovine tuberculosis.

M A Skinner1, D L Keen, N A Parlane, K L Hamel, G F Yates, B M Buddle.   

Abstract

Possums are a wildlife vector of bovine tuberculosis in New Zealand. Vaccination of possums with BCG is being considered as a measure to control the spread of bovine tuberculosis to cattle and deer. Delivery via oral bait is feasible but BCG is degraded in the stomach. The aim was to determine whether ranitidine (Zantac) would reduce gastric acidity and enhance the efficacy of intragastrically administered BCG. A dose of 75 mg reduced gastric acidity for at least 4 h. Thus, possums were vaccinated intragastrically with BCG after receiving 75 mg ranitidine or ranitidine or BCG alone, as controls, before challenge with virulent Mycobacterium bovis. Proliferative responses of blood lymphocytes to M. bovis antigens after vaccination were significantly higher in possums given ranitidine/BCG compared to controls and seven weeks after challenge they had significantly lower lung weights and spleen bacterial counts than ranitidine alone controls. Vaccination with BCG alone only gave a reduction in loss in body weight. Agents that reduce gastric acidity may be useful in formulating BCG for oral bait delivery to wildlife for vaccination against bovine tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15766942     DOI: 10.1016/j.rvsc.2004.07.007

Source DB:  PubMed          Journal:  Res Vet Sci        ISSN: 0034-5288            Impact factor:   2.534


  8 in total

1.  Oral vaccination reduces the incidence of tuberculosis in free-living brushtail possums.

Authors:  D M Tompkins; D S L Ramsey; M L Cross; F E Aldwell; G W de Lisle; B M Buddle
Journal:  Proc Biol Sci       Date:  2009-06-03       Impact factor: 5.349

2.  Oral vaccination of guinea pigs with a Mycobacterium bovis bacillus Calmette-Guerin vaccine in a lipid matrix protects against aerosol infection with virulent M. bovis.

Authors:  Simon Clark; Martin L Cross; Allan Nadian; Julia Vipond; Pinar Court; Ann Williams; R Glyn Hewinson; Frank E Aldwell; Mark A Chambers
Journal:  Infect Immun       Date:  2008-06-02       Impact factor: 3.441

3.  Field Trial of an Aerially-Distributed Tuberculosis Vaccine in a Low-Density Wildlife Population of Brushtail Possums (Trichosurus vulpecula).

Authors:  Graham Nugent; Ivor J Yockney; E Jackie Whitford; Martin L Cross; Frank E Aldwell; Bryce M Buddle
Journal:  PLoS One       Date:  2016-11-28       Impact factor: 3.240

Review 4.  Development and Challenges in Animal Tuberculosis Vaccination.

Authors:  Ana Balseiro; Jobin Thomas; Christian Gortázar; María A Risalde
Journal:  Pathogens       Date:  2020-06-15

Review 5.  Efficacy and Safety of BCG Vaccine for Control of Tuberculosis in Domestic Livestock and Wildlife.

Authors:  Bryce M Buddle; Hans Martin Vordermeier; Mark A Chambers; Lin-Mari de Klerk-Lorist
Journal:  Front Vet Sci       Date:  2018-10-26

6.  Survival of Mycobacterium bovis BCG oral vaccine during transit through a dynamic in vitro model simulating the upper gastrointestinal tract of badgers.

Authors:  Gareth A Williams; Marjorie E Koenen; Robert Havenaar; Paul Wheeler; Sonya Gowtage; Sandrine Lesellier; Mark A Chambers
Journal:  PLoS One       Date:  2019-04-19       Impact factor: 3.240

7.  In Vitro Evaluation of Eudragit Matrices for Oral Delivery of BCG Vaccine to Animals.

Authors:  Imran Saleem; Allan G A Coombes; Mark A Chambers
Journal:  Pharmaceutics       Date:  2019-06-10       Impact factor: 6.321

Review 8.  The Evolution of Stomach Acidity and Its Relevance to the Human Microbiome.

Authors:  DeAnna E Beasley; Amanda M Koltz; Joanna E Lambert; Noah Fierer; Rob R Dunn
Journal:  PLoS One       Date:  2015-07-29       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.